Nektar to Announce Year-End 2008 Financial Results on Wednesday, February 25, 2009 After Close of U.S.-Based Financial Markets
The press release and a live audio-only Webcast of the conference call canbe accessed through a link that is posted on the home page and InvestorRelations section of the Nektar website: http://www.nektar.com.
An audio replay will also be available shortly after the call and willremain so through March 4, 2009.
In the event that any non-GAAP financial measure is discussed on theconference call that is not described in the press release, relatedinformation will be made available on the Investor Relations page at theNektar website as soon as practical after the conclusion of the conferencecall.
Nektar Therapeutics is a biopharmaceutical company developing noveltherapeutics based on its advanced polymer conjugation technology platforms.Nektar's technology and drug development expertise have enabled nine approvedproducts for partners, which include leading biopharmaceutical companies.Nektar is also developing a robust pipeline of its own potentially high-valuetherapeutics that addresses unmet medical needs by leveraging and expandingits technology platforms to improve and enable molecules. More information onNektar is available at http://www.nektar.com
Jennifer Ruddock, 650-631-4954, Nektar Therapeutics
Susan A. Noonan, 212-966-3650, The SAN GroupTo access the conference call, follow these instructions: Dial: 800.561.2718 (U.S.); 617.614.3525 (international) Participant Passcode: 32041145 (Howard Robin is the host)
SOURCE Nektar Therapeutics
You May Also Like